Mucormycosis: An emerging dangerous complication of Covid-19 disease

Mucormycosis, a rare, but severe angio-invasive disease that can have a catastrophic or fatal outcome. It was first reported by Friedrich Küchenmeister in 1855. Pulmonary mucormycosis was the first described by Julius Friedrich Cohnheim in 1865 and by Paul Walther Fürbringer in 1876. The aim of this book is to document the emergence of mucormycosis as a dangerous complication of covid-19 in Iraq and many countries in the world.On the first of June, 1,201,352 cases of covid-19 were reported by the Iraqi Ministry of Health, and 16375 patients died because of the disease. During, the first week of June, 2021, the death of Iraqi three patients having covid-19 disease complicated by mucormycosis was reported. At least 140 patients with covid-19 disease complicated by mucormycosis have been reported throughout the world. Forty patients with covid-19 with mucormycosis died including, 15 patients from India, eight patients from Iran, seven from Turkey, four deaths from USA, two deaths from Egypt, on death from Brazil, one death from Austria, one death from Mexico, and one death from the United Kingdom.